| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sharad Philip, Ashna Jose, Lidiya Silvester, Avinash Shekhar, Geo George, Midhun Dharan Sudha, Shamnad Najee. Clozapine and Ogilvie syndrome in Schizophrenia: Case report of a successful rechallenge. Asian journal of psychiatry. vol 77. 2022-09-12. PMID:36095882. |
clozapine and ogilvie syndrome in schizophrenia: case report of a successful rechallenge. |
2022-09-12 |
2023-08-14 |
Not clear |
| Maolin Hu, Yan Xia, Xiaofen Zong, John A Sweeney, Jeffrey R Bishop, Yanhui Liao, Gina Giase, Bingshan Li, Leah H Rubin, Yunpeng Wang, Zongchang Li, Ying He, Xiaogang Chen, Chunyu Liu, Chao Chen, Jinsong Tan. Risperidone-induced changes in DNA methylation in peripheral blood from first-episode schizophrenia patients parallel changes in neuroimaging and cognitive phenotypes. Psychiatry research. vol 317. 2022-09-08. PMID:36075150. |
as a biomarker for the susceptibility of schizophrenia and clozapine treatment response, dna methylation (dnam) has been studied, but the impact of antipsychotics on dnam has not been explored in drug-naïve patients. |
2022-09-08 |
2023-08-14 |
Not clear |
| Tomás Teodoro, Violeta Nogueira, Joana Aldeias, Marina Teles Martins, José Salgad. Clozapine Associated Periorbital Edema in First Episode Psychosis: A Case Report of a Rare Adverse Effect in Treatment-Resistant Schizophrenia. Journal of clinical psychopharmacology. 2022-09-06. PMID:36066404. |
clozapine associated periorbital edema in first episode psychosis: a case report of a rare adverse effect in treatment-resistant schizophrenia. |
2022-09-06 |
2023-08-14 |
Not clear |
| Juliette Lagreula, Philippe de Timary, Laure Elens, Olivia Dalleu. Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisation. Therapeutic advances in psychopharmacology. vol 12. 2022-09-02. PMID:36051501. |
antipsychotic polypharmacy (app) prescribing and clozapine underuse are considered inappropriate prescribing in schizophrenia. |
2022-09-02 |
2023-08-14 |
Not clear |
| Aya Torii-Goto, Akira Yoshimi, Yuko Tashiro, Mako Ukigai, Aoi Matsumoto, Norio Ozaki, Yukihiro Nod. A Reactive Metabolite of Clozapine Induces Hematopoietic Toxicity in HL-60 Cells Undergoing Granulocytic Differentiation through Its Effect on Glutathione Metabolism. Biological & pharmaceutical bulletin. vol 45. issue 9. 2022-09-01. PMID:36047190. |
clozapine is an atypical antipsychotic with several advantages over conventional antipsychotics, in addition to its well-known efficacy in treatment-resistant schizophrenia. |
2022-09-01 |
2023-08-14 |
Not clear |
| Hannah St Francis, Madeline H Renny, Rana Biary, Mary Ann Howland, Mark K S. Clozapine Toxicity in Two Young Siblings Due to a Pharmacy Dispensing Error: a Pediatric Case Report. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2022-08-26. PMID:36018467. |
clozapine is an atypical antipsychotic used to treat refractory schizophrenia; in both therapeutic use and overdose, it can cause significant toxicity. |
2022-08-26 |
2023-08-14 |
Not clear |
| Kotaro Sugita, Yasuhiro Mori, Kousuke Kanemoto, Sotaro Sugit. Long-lasting leukocytosis in patients with schizophrenia treated with clozapine after electroconvulsive therapy : ECT stabilizes white blood cell count. Science progress. vol 105. issue 3. 2022-08-24. PMID:36000301. |
long-lasting leukocytosis in patients with schizophrenia treated with clozapine after electroconvulsive therapy : ect stabilizes white blood cell count. |
2022-08-24 |
2023-08-14 |
Not clear |
| Kotaro Sugita, Yasuhiro Mori, Kousuke Kanemoto, Sotaro Sugit. Long-lasting leukocytosis in patients with schizophrenia treated with clozapine after electroconvulsive therapy : ECT stabilizes white blood cell count. Science progress. vol 105. issue 3. 2022-08-24. PMID:36000301. |
the present study was conducted to investigate the possible hematologic impact of long-term electroconvulsive therapy (ect) in patients with drug-resistant schizophrenia and receiving clozapine therapy. |
2022-08-24 |
2023-08-14 |
Not clear |
| C U Correll, Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, Andrea Fagiolini, Niko Seppälä, Oliver D Howe. Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia. CNS drugs. 2022-08-17. PMID:35976566. |
correction: a guideline and checklist for initiating and managing clozapine treatment in patients with treatment-resistant schizophrenia. |
2022-08-17 |
2023-08-14 |
Not clear |
| Leeba Rezaie, Azadeh Nazari, Habibolah Khazai. Exploration of the Barriers to Clozapine Prescribing in Patients with Treatment-Resistant Schizophrenia: A Qualitative Study. Journal of psychosocial rehabilitation and mental health. 2022-08-15. PMID:35967884. |
exploration of the barriers to clozapine prescribing in patients with treatment-resistant schizophrenia: a qualitative study. |
2022-08-15 |
2023-08-14 |
human |
| Andrea de Bartolomeis, Annarita Barone, Licia Vellucci, Benedetta Mazza, Mark C Austin, Felice Iasevoli, Mariateresa Ciccarell. Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review. Molecular neurobiology. 2022-08-13. PMID:35963926. |
finally, the link between altered inflammatory/immune responses raises relevant questions regarding potential new therapeutic strategies specifically for those forms of schizophrenia that are resistant to canonical antipsychotics or unresponsive to clozapine. |
2022-08-13 |
2023-08-14 |
Not clear |
| Leeba Rezaie, Azadeh Nazari, Roya Safari-Faramani, Shamarina Shohaimi, Habibolah Khazai. Iranian psychiatrists' attitude towards clozapine use for patients with treatment-resistant schizophrenia: a nationwide survey. BMC psychiatry. vol 22. issue 1. 2022-08-06. PMID:35933353. |
iranian psychiatrists' attitude towards clozapine use for patients with treatment-resistant schizophrenia: a nationwide survey. |
2022-08-06 |
2023-08-14 |
Not clear |
| Nazanin Vaziri, Diogo Marques, Xuemei Wang, Pranav Machiraju, Ankita Narang, Katerina Vlahos, Christos Pantelis, Steven C Greenway, Chad A Bousma. Generation of two human induced pluripotent stem cell lines from peripheral blood mononuclear cells of clozapine-tolerant and clozapine-induced myocarditis patients with treatment-resistant schizophrenia. Stem cell research. vol 63. 2022-08-02. PMID:35917601. |
clozapine has superior efficacy in the treatment of refractory schizophrenia; however, use of clozapine is limited due to severe side effects, including myocarditis. |
2022-08-02 |
2023-08-14 |
human |
| Yu Funahashi, Yuta Yoshino, Jun-Ichi Iga, Shu-Ichi Uen. Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2022-07-29. PMID:35904423. |
impact of clozapine on the expression of mir-675-3p in plasma exosomes derived from patients with schizophrenia. |
2022-07-29 |
2023-08-14 |
Not clear |
| Yu Funahashi, Yuta Yoshino, Jun-Ichi Iga, Shu-Ichi Uen. Impact of clozapine on the expression of miR-675-3p in plasma exosomes derived from patients with schizophrenia. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2022-07-29. PMID:35904423. |
the aim of this study was to investigate the global expression changes of mirna derived from the plasma exo of patients with treatment-resistant schizophrenia (trs) and the effects of clozapine on mirna expression. |
2022-07-29 |
2023-08-14 |
Not clear |
| Maria Skokou, Eleni A Karavia, Zoi Drakou, Vassiliki Konstantinopoulou, Christina-Anna Kavakioti, Philippos Gourzis, Kyriakos E Kypreos, Ourania Andreopoulo. Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review. Pharmaceuticals (Basel, Switzerland). vol 15. issue 7. 2022-07-27. PMID:35890117. |
clozapine is the gold standard for treatment-resistant schizophrenia. |
2022-07-27 |
2023-08-14 |
Not clear |
| Lara Moreno-Sancho, Maria Juncal-Ruiz, Javier Vázquez-Bourgon, Victor Ortiz-Garcia de la Foz, Jacqueline Mayoral-van Son, Diana Tordesillas-Gutierrez, Esther Setien-Suero, Rosa Ayesa-Arriola, Benedicto Crespo-Facorr. Naturalistic study on the use of clozapine in the early phases of non-affective psychosis: A 10-year follow-up study in the PAFIP-10 cohort. Journal of psychiatric research. vol 153. 2022-07-25. PMID:35878537. |
clozapine is seldom prescribed in treatment-resistant schizophrenia (trs) patients during early phases of the illness. |
2022-07-25 |
2023-08-14 |
human |
| Lara Moreno-Sancho, Maria Juncal-Ruiz, Javier Vázquez-Bourgon, Victor Ortiz-Garcia de la Foz, Jacqueline Mayoral-van Son, Diana Tordesillas-Gutierrez, Esther Setien-Suero, Rosa Ayesa-Arriola, Benedicto Crespo-Facorr. Naturalistic study on the use of clozapine in the early phases of non-affective psychosis: A 10-year follow-up study in the PAFIP-10 cohort. Journal of psychiatric research. vol 153. 2022-07-25. PMID:35878537. |
our findings reinforce the need of a timely assessment of treatment-resistant criteria in early schizophrenia patients and highlight the long-term benefits of an early introduction of clozapine on those patients meeting treatment-resistant criteria. |
2022-07-25 |
2023-08-14 |
human |
| Gregg Alan Robbins-Welty, Shannon Coats, Andrew N Tuck, Bryan K Lao, Zachary Lan. Pulmonary Embolism during a Retrial of Low-dose Clozapine. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology. vol 20. issue 3. 2022-07-25. PMID:35879043. |
we present a case of a 34-year-old with treatment-refractory schizophrenia who developed rhabdomyolysis during his first clozapine trial. |
2022-07-25 |
2023-08-14 |
Not clear |
| Juan D Duque-Yemail, Juan Carlos Avil. Switching Clozapine to Cariprazine in Three Patients with Persistent Symptoms of Schizophrenia: A Case Series. Neuropsychiatric disease and treatment. vol 18. 2022-07-21. PMID:35859803. |
switching clozapine to cariprazine in three patients with persistent symptoms of schizophrenia: a case series. |
2022-07-21 |
2023-08-14 |
Not clear |